Starpharma today released its Appendix 4C – Quarterly Cashflow report for the period ended 31 December 2015.

Starpharma announced it has completed its Share Purchase Plan (SPP) having raised approximately $1.9 million. Combining the SPP with the recent institutional placement which raised $32 million (before costs); the Company has successfully raised a total of approximately $34 million at $0.73 per share.